publication venue for
- Association between menopausal hormone therapy use and mortality risk: a Swedish population-based matched cohort study. 2022
- Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers.. 58. 2019
- A theoretical investigation of adequate range uncertainty margins in proton treatment planning to preserve tumor control probability.. 58. 2019
- Spatial rectal dose/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer.. 56. 2017
- Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.. 56. 2017
- Are fiducial markers useful surrogates when using respiratory gating to reduce motion of gastroesophageal junction tumors?. 55. 2016
- Central nervous system involvement in T-cell lymphoma: A single center experience.. 55. 2016
- Relationships between dose to the gastro-intestinal tract and patient-reported symptom domains after radiotherapy for localized prostate cancer.. 54. 2015
- Predictors of acute toxicities during definitive chemoradiation using intensity-modulated radiotherapy for anal squamous cell carcinoma.. 55. 2015
- Dose-volume factors correlating with trismus following chemoradiation for head and neck cancer.. 55. 2015
- Predicting radiation-induced valvular heart damage.. 54. 2015
- Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial.. 53. 2013
- Statistical simulations to estimate motion-inclusive dose-volume histograms for prediction of rectal morbidity following radiotherapy.. 52. 2012
- A dose-response relationship for time to bone pain resolution after stereotactic body radiotherapy (SBRT) for renal cell carcinoma (RCC) bony metastases.. 51. 2012
- Developing imaging strategies for castration resistant prostate cancer.. 50 Suppl 1. 2011
- Normal Tissue Complication Probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: A Test of the QUANTEC-recommended NTCP model.. 49. 2010
- Heart irradiation as a risk factor for radiation pneumonitis.. 50. 2010
- Datamining approaches for modeling tumor control probability.. 49. 2010
- Broadening the scope of image-guided radiotherapy (IGRT).. 47. 2008
- Non-invasive molecular and functional imaging of cytosine deaminase and uracil phosphoribosyltransferase fused with red fluorescence protein.. 47. 2008
- Cytotoxic treatment of aggressive prostate tumors with or without neuroendocrine elements.. 41. 2002
- Alterations in head and neck cancer occurring in HIV-infected patients--results of a pilot, longitudinal, prospective study.. 38. 1999
- Energy status parameters, hypoxia fraction and radiocurability across tumor types.. 34. 1995
- Circulating pancreatic polypeptide in patients with adenocarcinoma of the bile duct.. 32. 1993
- Bone marrow evaluation in small cell carcinoma of the lung.. 26. 1987
- Thymic malignancies treated with active scanning proton beam radiation and Monte Carlo planning: early clinical experience.. 60. 2021
- Keratoacanthomas associated with imatinib mesylate.. 50. 2010
- A petition for all patients with hidradenitis suppurativa to receive the HPV vaccine. 2020
- Advancing our quantitative understanding of radiotherapy normal tissue morbidity.. 53. 2014
- Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship. 2015
- Tumor markers in prostate cancer I: blood-based markers. 2011